NCT00791622View on ClinicalTrials.gov

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

June 30, 2006

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00791622 - A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine | Biotech Hunter | Biotech Hunter